Masimo Corp (FRA:3M4)
€ 120.8 -0.9 (-0.74%) Market Cap: 6.52 Bil Enterprise Value: 7.27 Bil PE Ratio: 89.29 PB Ratio: 5.10 GF Score: 88/100

Masimo Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 08:40PM GMT
Release Date Price: €232 (+2.65%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good afternoon. Thanks for joining us for a fireside chat session here in the med tech track with management from Masimo. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst. And I am joined by Micah Young, the Chief Financial Officer of Masimo; and also Eli Kammerman, who runs the investor relations function and yes, works in the business development group as well. So guys, thanks a lot for joining us today for this fireside chat discussion here virtually.

Micah Young
Masimo Corporation - Executive VP of Finance & CFO

All right. Thank you, Matt.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. All right. So just so everyone knows, I think at this point, they should, but if you have questions during the session, e-mail me or you can submit questions through the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot